Substances · Benzodiazepines and thienodiazepines
Flubromazepam
- Preferred name
- Flubromazepam
- IUPAC name
- 7-bromo-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one
- Parent CAS number (reference)
- 2647-50-9
- Molecular formula
- C15H10BrFN2O
- Molecular weight
- 333.15 g/mol
- InChIKey
- ZRKDDZBVSZLOFS-UHFFFAOYSA-N
- PubChem
- CID 12947024
- Source
- PubChem
- Verified synonyms & catalog abbreviations
-
Ro 05-2904 7-Bromo-2'-fluorodesmethyldiazepam
Matching Listings in This Store's Catalog
Verified Neurochemical & Toxicological Intelligence
Flubromazepam
Receptor Telemetry & Mechanism of Action
7-Bromo-2'-fluoro-1,4-benzodiazepin-2-one acting as a classic full GABA-A PAM with an elimination half-life exceeding 100 hours in human pharmacokinetic studies.
Biotransformation & Active Metabolites
Human pharmacokinetic study (Moosmann et al.) documents a ~106-hour terminal half-life via monohydroxylated metabolites.
Temporal Pharmacokinetics
Ultra-Long Half-Life GABA-A PAM — Lower milligram potency per 1 mg tablet (common literature range 4–8 mg), but extreme ~106 h half-life means slow onset (up to 2 h) and severe multi-day accumulation hazard if repeated before clearance.
- Onset 45–120 min
- Peak Window 3–6 h
- Total Window 12–24 h
- Residual / Half-Life 36–72+ h residual (T1/2 ~106 h)
Lower milligram potency per 1 mg tablet (common literature range 4–8 mg), but extreme ~106 h half-life means slow onset (up to 2 h) and severe multi-day accumulation hazard if repeated before clearance.
Quantitative Response Spectrum (Published Literature)
Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.
2 mg
Subtle threshold receptor activity (Ultra-Long Half-Life GABA-A PAM).
Minimal baseline autonomic shift.
2–4 mg
Mild, clear-headed expression of primary class profile.
Light somatic modulation.
4–8 mg
Full characteristic neurochemical and perceptual profile documented in literature.
Moderate somatic relaxation, ataxia, or autonomic tone depending on class.
8–12 mg
Pronounced intensity, cognitive/motor impairment, or deep immersion.
Marked somatic load and heightened adverse-event sensitivity.
14+ mg
Amnesia, blackout, acute dysphoria, confusion, or anesthetic dissociation.
High toxicity zone: severe motor loss, cardiovascular strain, or respiratory hazard.
Interaction Matrix & Critical Contraindications
Critical Hazard — Never Combine
Synergistic brainstem respiratory depression causing unconsciousness and fatal respiratory arrest.
Extreme CNS depression, complete anterograde amnesia, loss of airway reflexes, and fatal aspiration.
Elevated Hazard — Avoid
Unpredictable sedation, severe motor ataxia, blackout, and emesis aspiration hazard.
Caution / Receptor Attenuation
CYP3A4 inhibitors prolong plasma half-life; stimulants mask sedation until they wear off.
Structural Isomer & Sibling Comparison
Lower milligram potency per 1 mg tablet (common literature range 4–8 mg), but extreme ~106 h half-life means slow onset (up to 2 h) and severe multi-day accumulation hazard if repeated before clearance.
Physicochemical Stability & Storage
Physical Form: Precision-pressed 1 mg analytical tablets (1 tablet = 1 mg). · Parent molecule soluble in ethanol, propylene glycol, and DMSO; sparingly soluble in water.
Store sealed in a cool, dry, light-protected container away from humidity.
Cross-Tolerance & Dependence Profile
Complete cross-tolerance across all GABA-A benzodiazepines/thienodiazepines. Rapid physical dependence develops with continuous daily exposure; abrupt cessation after prolonged intake can trigger life-threatening rebound seizures and delirium.
Spot-test and isomer verification
Spot-test notes for flubromazepam. On 1 mg tablets, inert pharmaceutical excipients are more than 98% of the tablet mass and mask colorimetric shifts, so Marquis, Mecke, and Simon's are non-diagnostic. Zimmermann gives reddish-purple on pure 1,4-benzodiazepin-2-ones such as diclazepam, norflurazepam, flubromazepam, and gidazepam.
Verification requires solvent extraction (MeOH or MeCN) followed by LC-MS/MS or GC-MS, reading the ⁷⁹Br/⁸¹Br or ³⁵Cl/³⁷Cl isotope pattern.
Codes on this card
Short meanings for the abbreviations printed with this substance.
DAT
Dopamine transporter
DAT is the protein that collects dopamine back from the gap between nerve cells. A card that names DAT is quoting a laboratory result about that protein.
GABAₐ
GABA-A positive modulator
GABA-A is the main inhibitory receptor for the messenger GABA. A positive modulator does not replace GABA. It makes GABA's own signal stronger when GABA is already there.
NMDA
NMDA glutamate channel
NMDA is a glutamate receptor that works like a gated channel. Ketamine-type and PCP-type cards cite it when papers describe that channel as blocked.
ratio
Selectivity ratio
A selectivity ratio divides two halfway numbers, such as SERT EC50 by DAT EC50, to show which target the assay reached first. The direction of the division has to be stated, or the number flips.
T½
Half-life
Half-life is the time it takes a measured concentration to fall by half. After one half-life, half remains. After another, a quarter of the original measurement remains.
1 mg / µg
Calibrated Physical Form (1 mg Tablets, µg Liquid, Crystal)
Milligram-scale benzodiazepines are supplied as 1 mg tablets (1 tablet = 1 mg), microgram lysergamides as dissolved liquid (µg), and standard compounds as pure crystal or powder.
OUN / Oddech
Synergistic CNS & Respiratory Depression
Combining two central nervous system depressants (such as benzodiazepines, alcohol, GHB, or opioids) multiplies sedation and can suppress brainstem breathing drive.
Tolerancja ×
Cross-Tolerance
When exposure to one compound reduces sensitivity to other compounds that act on the same receptor family (for example across all 5-HT2A lysergamides or all GABA-A modulators).
Chemical Architecture & Structural Profile
Flubromazepam (7-bromo-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one) is a reference compound belonging to the Benzodiazepines and thienodiazepines class, characterized by the molecular formula C15H10BrFN2O and a molar mass of 333.15 g/mol. The parent molecule is indexed under CAS registry number 2647-50-9 and in the NCBI PubChem database as CID 12947024 (Standard InChIKey: ZRKDDZBVSZLOFS-UHFFFAOYSA-N).
Citations
- PubChem — PubChem (2026-11-12)
Reference Toxicology & Safety Profile
In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), Flubromazepam is indexed within the Benzodiazepines structural group. Toxicological notes (PsychonautWiki): low toxicity, potentially lethal when mixed with depressants like alcohol or opioids. Dependence liability (PsychonautWiki): extremely physically and psychologically addictive. Documented cross-tolerance class: benzodiazepines. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.
Citations
- PubChem — PubChem (2026-11-12)
Analytical Use & Laboratory Notice
This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.
Citations
- Gesetze im Internet — Neue-psychoaktive-Stoffe-Gesetz (NpSG) & BtMG — Bundesministerium der Justiz (2026-11-12)